Text Size

Study Evaluation LXR-623 in Healthy Adults

This study has been terminated.
Sponsor:
Information provided by:
Wyeth is now a wholly owned subsidiary of Pfizer
ClinicalTrials.gov Identifier:
NCT00379860
First received: September 21, 2006
Last updated: March 8, 2007
Last verified: March 2007
History of Changes
  Purpose

To evaluate the safety and tolerability of multiple doses of LXR in healthy adults.


Condition Intervention Phase
Healthy Subjects
 Drug: LXR-623
 Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: A Multiple Ascending Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of LXR-623 Administered Orally to Healthy Subjects

Further study details as provided by Wyeth is now a wholly owned subsidiary of Pfizer:

Primary Outcome Measures:
  • Safety is the primary outcome.

Study Start Date: October 2006
Estimated Study Completion Date: January 2007
  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Generally healthy adults.
  • Liver function tests, triglycerideres, and creatinine must be below upper limit of normal at screening.

Exclusion Criteria:

  • A history or active presence of clinically important medical disease.
  • Any metal implants or devices.
  • Claustrophobia.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00379860

Sponsors and Collaborators
Wyeth is now a wholly owned subsidiary of Pfizer
Investigators
Study Director: Medical Monitor Wyeth is now a wholly owned subsidiary of Pfizer
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00379860     History of Changes
Other Study ID Numbers: 3201A1-101
Study First Received: September 21, 2006
Last Updated: March 8, 2007
Health Authority: United States: Food and Drug Administration

ClinicalTrials.gov processed this record on June 18, 2013